Literature DB >> 16400031

Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness.

Federica Sotgia1, Terence M Williams, William Schubert, Freddy Medina, Carlo Minetti, Richard G Pestell, Michael P Lisanti.   

Abstract

During breast cancer development, the luminal space of the mammary acinar unit fills with proliferating epithelial cells that exhibit growth factor-independence, cell attachment defects, and a more invasive fibroblastic phenotype. Here, we used primary cultures of mammary epithelial cells derived from genetically engineered mice to identify caveolin-1 (Cav-1) as a critical factor for maintaining the normal architecture of the mammary acinar unit. Isolated cultures of normal mammary epithelial cells retained the capacity to generate mammary acini within extracellular matrix. However, those from Cav-1 (-/-) mice exhibited defects in three-dimensional acinar architecture, including disrupted lumen formation and epidermal growth factor-independent growth due to hyperactivation of the p42/44 mitogen-activated protein kinase cascade. In addition, Cav-1-null mammary epithelial cells deprived of exogenous extracellular matrix underwent a spontaneous epithelial-mesenchymal transition, with reorganization of the actin cytoskeleton, and E-cadherin redistribution. Mechanistically, these phenotypic changes appear to be caused by increases in matrix metalloproteinase-2/9 secretion and transforming growth factor-beta/Smad-2 hyperactivation. Finally, loss of Cav-1 potentiated the ability of growth factors (hepatocyte growth factor and basic fibroblast growth factor) to induce mammary acini branching, indicative of a more invasive fibroblastic phenotype. Thus, a Cav-1 deficiency profoundly affects mammary epithelia by modulating the activation state of important signaling cascades. Primary cultures of Cav-1-deficient mammary epithelia will provide a valuable new model to study the spatial/temporal progression of mammary cell transformation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16400031      PMCID: PMC1592656          DOI: 10.2353/ajpath.2006.050429

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  83 in total

1.  Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism.

Authors:  D S Park; B Razani; A Lasorella; N Schreiber-Agus; R G Pestell; A Iavarone; M P Lisanti
Journal:  Biochemistry       Date:  2001-03-20       Impact factor: 3.162

Review 2.  Matrix metalloproteinases: they're not just for matrix anymore!

Authors:  L J McCawley; L M Matrisian
Journal:  Curr Opin Cell Biol       Date:  2001-10       Impact factor: 8.382

3.  Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor.

Authors:  B Razani; X L Zhang; M Bitzer; G von Gersdorff; E P Böttinger; M P Lisanti
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

4.  Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity.

Authors:  F C Bender; M A Reymond; C Bron; A F Quest
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

5.  Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta.

Authors:  J Zavadil; M Bitzer; D Liang; Y C Yang; A Massimi; S Kneitz; E Piek; E P Bottinger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

6.  ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini.

Authors:  S K Muthuswamy; D Li; S Lelievre; M J Bissell; J S Brugge
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

7.  Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation.

Authors:  B Razani; Y Altschuler; L Zhu; R G Pestell; K E Mostov; M P Lisanti
Journal:  Biochemistry       Date:  2000-11-14       Impact factor: 3.162

8.  Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.

Authors:  A V Bakin; A K Tomlinson; N A Bhowmick; H L Moses; C L Arteaga
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

9.  Invasion activating caveolin-1 mutation in human scirrhous breast cancers.

Authors:  K Hayashi; S Matsuda; K Machida; T Yamamoto; Y Fukuda; Y Nimura; T Hayakawa; M Hamaguchi
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

10.  Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism.

Authors:  N A Bhowmick; M Ghiassi; A Bakin; M Aakre; C A Lundquist; M E Engel; C L Arteaga; H L Moses
Journal:  Mol Biol Cell       Date:  2001-01       Impact factor: 4.138

View more
  31 in total

1.  Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.

Authors:  Tianhong Li; Federica Sotgia; Magalis A Vuolo; Maomi Li; Wan Cai Yang; Richard G Pestell; Joseph A Sparano; Michael P Lisanti
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 2.  Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranes.

Authors:  Michael R Freeman; Bekir Cinar; Jayoung Kim; Nishit K Mukhopadhyay; Dolores Di Vizio; Rosalyn M Adam; Keith R Solomon
Journal:  Steroids       Date:  2006-12-14       Impact factor: 2.668

Review 3.  Caveolin proteins and estrogen signaling in the brain.

Authors:  Jessie I Luoma; Marissa I Boulware; Paul G Mermelstein
Journal:  Mol Cell Endocrinol       Date:  2008-04-22       Impact factor: 4.102

4.  Pilot study on the effects of dietary conjugated linoleic acid on tumorigenesis and gene expression in PyMT transgenic mice.

Authors:  Margaret Flowers; Joyce A Schroeder; Alexander D Borowsky; David G Besselsen; Cynthia A Thomson; Ritu Pandey; Patricia A Thompson
Journal:  Carcinogenesis       Date:  2010-07-11       Impact factor: 4.944

5.  Caveolin-1alpha and -1beta perform nonredundant roles in early vertebrate development.

Authors:  Ping-Ke Fang; Keith R Solomon; Liyan Zhuang; Maosong Qi; Mary McKee; Michael R Freeman; Pamela C Yelick
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

6.  Induction of the apoptosis inhibitor ARC by Ras in human cancers.

Authors:  Lily Wu; Young-Jae Nam; Gloria Kung; Michael T Crow; Richard N Kitsis
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

7.  Critical role of CAV1/caveolin-1 in cell stress responses in human breast cancer cells via modulation of lysosomal function and autophagy.

Authors:  Yin Shi; Shi-Hao Tan; Shukie Ng; Jing Zhou; Na-Di Yang; Gi-Bang Koo; Kerrie-Ann McMahon; Robert G Parton; Michelle M Hill; Miguel A Del Pozo; You-Sun Kim; Han-Ming Shen
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

8.  Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.

Authors:  Federica Sotgia; Francesco Del Galdo; Mathew C Casimiro; Gloria Bonuccelli; Isabelle Mercier; Diana Whitaker-Menezes; Kristin M Daumer; Jie Zhou; Chenguang Wang; Sanjay Katiyar; Huan Xu; Emily Bosco; Andrew A Quong; Bruce Aronow; Agnieszka K Witkiewicz; Carlo Minetti; Philippe G Frank; Sergio A Jimenez; Erik S Knudsen; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

9.  Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.

Authors:  Caterina Bianco; Luigi Strizzi; Mario Mancino; Kazuhide Watanabe; Monica Gonzales; Shin Hamada; Ahmed Raafat; Lawson Sahlah; Cindy Chang; Federica Sotgia; Nicola Normanno; Michael Lisanti; David S Salomon
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

10.  MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling.

Authors:  Rehan Ahmad; Deepak Raina; Vishal Trivedi; Jian Ren; Hasan Rajabi; Surender Kharbanda; Donald Kufe
Journal:  Nat Cell Biol       Date:  2007-11-25       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.